Related Experiment Videos
Development of a hybrid liver support system.
I M Sauer1, N Obermeyer, D Kardassis
1Medizinische Fakultät der Humboldt Universität zu Berlin, Klinik für Allgemein, Viszeralund Transplantationschirurgie, Germany. igor.sauer@charite.de
Annals of the New York Academy of Sciences
|January 19, 2002
Summary
Hybrid liver systems show promise for temporary extracorporeal liver support, demonstrating long-term metabolic function in bioreactors. Further clinical studies are needed to confirm efficacy in treating acute liver failure.
Area of Science:
- Biomedical Engineering
- Hepatology
- Regenerative Medicine
Background:
- Hybrid liver systems are under development for temporary extracorporeal liver support.
- Current research focuses on hepatocyte culture models for bioreactors and clinical applications.
Purpose of the Study:
- To review the development of hybrid liver systems for temporary liver support.
- To evaluate the potential of bioreactor-based systems for clinical therapy of acute liver failure.
Main Methods:
- In vitro studies using isolated primary hepatocytes in bioreactors.
- Animal experiments to assess bioreactor upscaling for clinical treatment.
- Design of a novel bioreactor for co-culture of hepatocytes and sinusoidal endothelial cells using capillary membrane systems.
Main Results:
- In vitro studies demonstrated long-term metabolic function of hepatocytes in bioreactors, supporting essential liver functions.
- Animal experiments suggested the feasibility of upscaling bioreactors.
- A novel bioreactor design facilitates decentralized oxygen and carbon dioxide exchange and easy upscaling.
Conclusions:
- Hybrid liver systems show potential for temporary liver support, with promising in vitro and animal study results.
- Limitations include the lack of reliable animal models for acute liver failure and insufficient clinical data.
- Ongoing research and competition highlight the dynamic development in this field, with novel bioreactor designs emerging.